Stocks / Pharmaceuticals

SDGRPharmaceuticals

Schrodinger, Inc.
$29.631d +23.8%5d +58.2%settled close · 2026-09-17
Mkt cap $854M (3/25)β 1.4952w $11.51–30Shares 64.7MInd. Pharmaceutical PreparationsNasdaq since 2020Emp. 850HQ New York, NYschrodinger.com
Who’s talkingIdea Scout · free

Who’s talking about SDGR

No tracked investor commentary on SDGR yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 3 Nov 2026

Confirmed date · consensus EPS -0.71. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where SDGR’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 14 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-17
2026-09-16
2026-09-15
2026-09-14
2026-08-21
2026-08-19
2026-08-11
2026-08-06
2026-08-05
2026-07-31
2026-07-14
2026-06-24
2026-06-04
2026-05-29
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on SDGR is in this morning’s Brief. Get The Brief — $20/mo →